Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia.
Saved in:
| Title: | Effect of Paxlovid treatment during acute COVID-19 on Long COVID onset: An EHR-based target trial emulation from the N3C and RECOVER consortia. |
|---|---|
| Authors: | Preiss A; RTI International, Durham, North Carolina, United States of America., Bhatia A; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Aragon LV; University of New Mexico, Albuquerque, New Mexico, United States of America., Baratta JM; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Baskaran M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Blancero F; RECOVER Community Representative, Bethesda, Maryland, United States of America., Brannock MD; RTI International, Durham, North Carolina, United States of America., Chew RF; RTI International, Durham, North Carolina, United States of America., Díaz I; New York University Grossman School of Medicine, New York, New York, United States of America., Fitzgerald M; Patient Led Research Collaborative, Calabasas, California, United States of America., Kelly EP; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Zhou AG; University of Virginia, Charlottesville, Virginia, United States of America., Carton TW; Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America., Chute CG; Johns Hopkins University School of Medicine, Public Health, and Nursing, Baltimore, Maryland, United States of America., Haendel M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Moffitt R; Emory University School of Medicine, Atlanta, Georgia, United States of America., Pfaff E; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. |
| Corporate Authors: | N3C Consortium and the RECOVER Cohort |
| Source: | PLoS medicine [PLoS Med] 2025 Sep 15; Vol. 22 (9), pp. e1004711. Date of Electronic Publication: 2025 Sep 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-1676 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004711 |
